companydata.dkCPHbiomedix ApS: Financial statements 2023
CVR: 43118676
CPHbiomedix ApS (CVR 43118676) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,291,883 and a net result of DKK 279,483 compared with DKK 313,910 the year before. That is a decrease of 3.7% compared with the year before. Equity amounted to DKK 3,339,876. The solvency ratio was 93.3%. The company had 1 employee in the financial year.
- Gross Profit
- 1,291,883 kr.
- Profit/Loss
- 279,483 kr.
- Equity
- 3,339,876 kr.
- Total Assets
- 3,581,287 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.3 mio. | 279 t. | 3.3 mio. | 1 |
| 2022 | - | 1.3 mio. | 314 t. | 3.1 mio. | 1 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
CPHbiomedix ApS has published its annual report for 2022. Gross profit came to DKK 1,341,829, and the net result was DKK 313,910.
About CPHbiomedix ApS
CPHbiomedix ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Claus Bo Vöge Christensen. The company is owned by Claus Bo Vöge Christensen. In 2025, the company reported a gross profit of DKK 473,967 and a net result of DKK -21,956 compared with DKK 237,468 the year before. Equity amounted to DKK 3,555,387.